- Faculty
- Health
- In the News
Pilot to Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects
Misako Nagasaka
A Study On:
- Lung
Status:
- Open
Eligibility
Adult
Interested in joining this trial?
Official Title
A Pilot Study to Assess the Diversity of Gut Microbiome in Metastatic Non-Small Cell Lung Cancer (NSCLC) in Correlation to Treatment Effects and Adverse Effects
Details
The purpose of this research study is to investigate the makeup of gut microbiome that occurs during the course of treatment for non-small cell lung cancer (NSCLC).
Eligibility
You can join if...
Please note this may not be a complete list of eligibility criteria. We have included a few examples ofstudy criteria to help you better understand how your eligibility in the study will be determined; your study
team will go through the study eligibility criteria with you to verify if you qualify for participation in this
study.
Inclusion Requirements
You can participate in this study if you
• Are 18 years of age or older
• Able to provide written informed consent
• Have advanced/metastatic non-small cell lung cancer
Exclusion Requirements
You cannot participate in this study if you
Are clinically unstable and need to focus on your treatment.
Get in touch with our study team
News & Events
UCI Health enrolls patient in first U.S. study of medical device for erectile dysfunction Sickle cell disease treatment nearing FDA approval - Faculty
- Health
- In the News
His GERD is now a distant memory - Faculty
- Health
- In the News